CAT3, a prodrug of 13a(S)-3-hydroxyl-6,7-dimethoxyphenanthro[9,10-b]-indolizidine, circumvents temozolomide-resistant glioblastoma via the Hedgehog signaling pathway, independently of O6-methylguanine DNA methyltransferase expression

M. Ji et al.

OncoTargets and Therapy (2018)

Institution: Institute of Materia Medica, China

Cell Line: U251/TMZ and T98G (TMZ-resistant glioblastoma cell lines)

Research Area: Cancer research

Tags: HoloMonitor M4, Cell count, Gli inhibitor, Chemotherapy, Lomeguatrib, Xenograft tumor model

Conclusions: The results indicate that CAT3 is a potential therapeutic agent for TMZ-resistant GBM (glioblastoma multiforme). HoloMonitor M4 was used to directly monitor and calculate the cell number.

Read the article …